Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$7.69 CAD
Change Today -0.23 / -2.90%
Volume 450.0
NVC On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ CM
Frankfurt
As of 3:04 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas Glen Janzen

Independent Director, Member of Audit Committee and Member of Compensation Committee, Neovasc Inc.
AgeTotal Calculated CompensationThis person is connected to 72 board members in 8 different organizations across 13 different industries.

See Board Relationships
46--

Background*

Mr. Douglas Glen Janzen, also known as Doug, serves as the Chairman and Chief Executive Officer at Aequus Pharmaceuticals Inc. Mr. Janzen serves as a Co-Founder and Managing Director at Northview LifeSciences. He served as the President and Chief Executive Officer at Cardiome Pharma Corp., from March 8, 2006 to July 2012 and from August 2009 to July 2012 respectively. Mr. Janzen served as the President at Aequus Pharmaceuticals Inc. from January 3, 2013 to July 2015. ...

Read Full Background

Corporate Headquarters*

13562 Maycrest Way
Richmond, British Columbia V6V 2J7

Canada

Phone: 604-270-4344
Fax: 604-270-4384

Board Members Memberships*

Director
Director
Director
Director
2005-Present
Independent Director, Member of Audit Committee and Member of Compensation Committee
2012-Present
Director
2013-Present
Chairman, Chief Executive Officer and President

Education*

Master's Degree
University Of British Columbia
Unknown/Other Education
University of Saskatchewan

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVC:CN C$7.69 CAD -0.23

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOVASC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.